Morgan Stanley »

Cytomx Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.9M 856k 2.18
2023-09-30 $82k 64k 1.29
2023-06-30 $145k 84k 1.72
2022-12-31 $29k 18k 1.60
2022-06-30 $306k 161k 1.89
2022-03-31 $200k 78k 2.58
2021-06-30 $4.0M 636k 6.33
2020-12-31 $2.0M 302k 6.55
2020-09-30 $52k 7.8k 6.62
2020-06-30 $216k 26k 8.32
2020-03-31 $205k 27k 7.63
2019-12-31 $558k 67k 8.31
2019-09-30 $187k 25k 7.40
2019-03-31 $1.2M 115k 10.76
2018-12-31 $1.3M 84k 15.10
2018-09-30 $1.8M 96k 18.51
2018-06-30 $2.5M 111k 22.85
2018-03-31 $3.8M 134k 28.45
2017-12-31 $2.1M 100k 21.11
2017-03-31 $916k 53k 17.26
2016-12-31 $700k 64k 10.98
2016-09-30 $75k 4.7k 15.80
2016-06-30 $14k 1.2k 12.42
2016-03-31 $13k 1.0k 13.00
2015-12-31 $111k 5.9k 18.75